Stroke Patients Improve with Stem Cells

Long-term stroke patients involved in a small-scale clinical trial of a neural stem-cell therapy show signs of recovery.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A colony of human embryonic stem cells (middle)WIKIMEDIA, RYDDRAGYNIt was thought that stroke victims couldn’t make any sort of recovery more than 6 months after the stroke. But now, five out of nine long-term stroke patients who took part in a Phase 1 clinical trial of a new therapy in which neural stem cells are injected into the damaged parts of the brain have experienced mild to moderate improvements, reported BBC News.

For example, some participants have recovered the ability to move their fingers and grip objects after several years of complete paralysis, while others are now able to walk around their houses without assistance for the first time in years.

“We are seeing things that are interesting and somewhat surprising,” Hugh Muir, a neuroscientist at the University of Glasgow who is leading the work, told the BBC. “My expectation had been that we would see very little change and if we did see change it would be a relatively short-lived temporary change,” added Muir. “[But] we have seen changes that have been maintained over time.”

The treatment was developed by the company ReNeuron, which first created the stem cells 10 years ago from a sample of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Dan Cossins

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio